Research programme: infectious diseases vaccines - GlaxoSmithKline/Oswald Cruz Foundation
Latest Information Update: 16 Jul 2016
At a glance
- Originator GlaxoSmithKline; Oswaldo Cruz Foundation
- Developer GSK
- Class Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Chagas disease; Leishmaniasis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Chagas'-disease in Brazil
- 16 Jul 2016 No recent reports of development identified for research development in Chagas'-disease in Spain
- 16 Jul 2016 No recent reports of development identified for research development in Leishmaniasis in Brazil